Department of Neurology and Neurological Sciences and the Stanford Stroke Center, Stanford University Hospital, Stanford, CA.
Top Magn Reson Imaging. 2021 Aug 1;30(4):205-209. doi: 10.1097/RMR.0000000000000284.
Intravenous thrombolysis is the cornerstone of acute ischemic stroke treatment. However, the benefits of recanalization and reperfusion must be balanced against the risk of intracranial hemorrhage. Time from symptom onset was previously the most important selection tool for identifying patients who would benefit from treatment without prohibitive risk for secondary hemorrhage. Enhanced techniques in noncontrast computed tomography followed by computed tomography and magnetic resonance perfusion imaging led to the expansion of treatment eligibility for intravenous thrombolysis. Perfusion imaging allows for more precise evaluation of tissue at-risk to identify patients who would benefit from treatment many hours beyond symptom onset.
静脉溶栓是急性缺血性脑卒中治疗的基石。然而,再通和再灌注的益处必须与颅内出血的风险相平衡。既往,从症状发作开始的时间是识别那些在不增加继发性出血风险的情况下受益于治疗的患者的最重要选择工具。非对比增强 CT 后 CT 和磁共振灌注成像等增强技术使静脉溶栓治疗的适应证扩大。灌注成像可以更精确地评估有风险的组织,以识别在症状发作后数小时仍受益于治疗的患者。